Categorized | Stock Profiles

XCHC (X-Change Corp.)

Share Button

xchcX-Change Corporation (XCHC) is a cosmeceutical, nutraceutical, and cardiovascular health industry company who is introducing a unique line of over-the-counter cosmetics and ailment products to actively participate in the global $55 billion Cosmeceutical, 2015’s forecasted $290 billion global Anti-Aging and Rejuvenating market, and a new involvement in the multi-billion dollar Medical Cannabis market.


Symbol: XCHC  [ Current PPS: $0.0375  Outstanding Shares: 67.8M  Float: 31.3M  – a/o September 5, 2013 ]

xchc chart



XCHC’s unique line of products are all composed with hemp oil which is scientifically known to improve good health as it contains all the essential amino acids and fatty acids the body requires and was previously part of a global dietary intake. Accordingly, XCHC is taking full advantage of the unique benefits of the hemp plant by developing a product line which will include, but not limited to, lip balms, supplements, extracts and dermal creams made at retail, professional, private-based, and physician-based levels. One such dermal cream under XCHC’s product line includes a high nutrient moisturizing cream created to help alleviate numerous skin issues and irritations such as eczema and psoriasis. However, additional company formulations have identified over a dozen ailments to aid cancer, influenza, HIV/AIDS, arthritis and post-traumatic stress disorder.



  • Cannabinoids have been found to aid AIDS/HIV, Alzheimers, Asthma, Autoimmune Disease, Cancer, Crohn’s Disease, Diabetes, Digestive Disover, Gastro Intestinal (GERD), Glaucoma, High Blood Pressure, Influenza, Multiple Sclerosis, Pain Management, and Tourette Syndrome
  • The use of cannabis as a natural remedy is said to have begun over 4,000 years ago and has since then been utilized as a globally known medicine specifically in China, India, and the Middle East to treat malaria, rheumatism, and constipation.
  • The Medical Marijuana Market is a $40 billion per year industry with some internal estimates placing it over $100 billion
  • There are 10 U.S States who approve of medical marijuana with 9 other states pending legislation including the 3rd most populous state in the nation; New York.
  • Research Analysts predict the Global HIV Drugs Market to reach a $15.5 billion market value by 2014
  • Global Alzheimer’s Disease Treatment is said to reach $9 billion by 2016
  • Anti-Aging market will reach $290 billion by 2015
  • By 2014, the Asthma and COPD drugs market will increase to $31 billion
  • U.S annual sales of Diabetes total an estimated $22 billion
  • The market for Diabetes medicine is forecasted to approach $65 billion by 2020.
  • The Global Medical Enzymes market is said to reach $7.2 billion by 2015
  • Global Glaucoma Pharmaceuticals is predicted to exceed $3.35 billion by 2015


Recent News

  • XCHC recently Expanded into Uruguay which is another country in South American to join the acceptance and legalization of medical marijuana worldwide.
  • CNN’s Dr. Sanjay Gupta, a renowned neurosurgeon and medical commentator, recently Declared His Support for medical cannabis after a child with a severe seizure syndrome received a life-saving medical cannabis treatment.
  • The company recently Entered into a Multi-Year Agreement with Medicine Dispensing Systems to provide XCHC with clinical and scientific expertise for 10 medical cannabis dispensaries and cultivation facilities to be located in the states of California, Arizona, Washington State, Nevada, Massachusetts, and Illinois.
  • A Recent Memo sent by U.S Deputy Attorney General, James Cole, of the Department of Justice to nationwide federal prosecutors detailed medical cannabis companies will not be penalized for their success in this market and will not sue U.S states to reverse the legalization yet to embrace the new market.


Get XCHC Updates by Signing Up to our Free E-mail Newsletter!

This post was written by:

- who has written 2169 posts on StockRockandRoll.

Contact the author

Comments are closed.

© 2021 MJ Capital, LLC | All rights reserved